Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-09-01Clinical Trial Update: Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides [Phase 3]
Phase 3 trial of Diazoxide Choline Controlled-Release Tablet (DCCR) for hypertriglyceridemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-01Clinical Trial Update: Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline [Phase 1]
The clinical trial NCT00901823, an open-label Phase 1 pharmacokinetic study of diazoxide choline for hypertriglyceridemia, has been withdraw…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia [NA]
This clinical trial update reports on the effect of therapeutic phlebotomies on triglyceride levels in patients with hypertriglyceridemia an…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) [Phase 1]
Phase 1 study evaluating potential drug-drug interaction between multiple doses of Epanova and a single dose of rosuvastatin (Crestor) in hy…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia [Phase 2]
This clinical trial update reports completion of a Phase 2 trial evaluating ARI-3037MO to reduce triglyceride levels in adults with severe h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome [Phase 4]
Clinical Trial Update describes a Phase 4 study comparing simvastatin with fenofibrate versus simvastatin alone in patients with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia [Phase 2]
Phase 2 pilot study evaluating CAT-2003 in patients with dyslipidemia was completed.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia [Phase 2]
A Phase 2 pilot study evaluating CAT-2003 for familial chylomicronemia syndrome and related lipid disorders has completed.
-
FDA approval · 2016-07-12FDA Approved: FENOFIBRATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' fenofibrate generic as an Original Application for the treatment of lipid disorders. The approval cover…
-
FDA approval · 2016-06-23FDA Approved: FENOFIBRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original generic application for fenofibrate from Mylan Pharmaceuticals Inc., enabling the marketing of a fenofibrate produ…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis [Phase 1]
Completed Phase 1 open-label crossover trial comparing the relative bioavailability, efficacy and safety of Epanova and Lovaza in men and wo…
-
FDA approval · 2016-06-17FDA Approved: GEMFIBROZIL — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals Limited's original ANDA for gemfibrozil, authorizing a generic version of the lipid-lowering drug.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight [Phase 2]
A Phase 2 clinical trial evaluating the effects of Glucodia on glucose parameters, triglycerides, and body weight has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Study to Assess the Safety and Tolerability of Single Doses of REGN1500 [Phase 1]
Phase 1 study evaluating the safety and tolerability of single doses of REGN1500 in hypertriglyceridemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides. [NA]
This completed clinical trial compared fenofibrate (Tricor), rosiglitazone (Avandia), and a weight-loss intervention to reduce cardiovascula…
-
FDA approval · 2016-05-05FDA Approved: FENOFIBRATE — Original Application (Aurobindo Pharma Limited)
FDA approves the original application (ANDA) for Fenofibrate manufactured by Aurobindo Pharma Limited, authorizing its generic fenofibrate p…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Efficacy of LCQ908 on Cardiovascular Risk [Phase 2]
Phase 2 trial evaluating LCQ908 for cardiovascular risk in coronary artery disease and hypertriglyceridemia was terminated, with results pos…
-
FDA approval · 2016-04-06FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for Lopid (gemfibrozil) submitted by Parke-Davis Div of Pfizer Inc, resulting in an approved modific…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia [Phase 4]
Phase 4 clinical trial evaluating omega-3 fatty acids (Lovaza) for hypertriglyceridemia associated with second-generation antipsychotics. Re…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [NA]
A completed clinical trial evaluated whether diet, exercise, niacin, and fenofibrate could reduce cardiovascular risk factors in people with…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Re-evaluating Triglycerides in Coronary Heart Disease
This NHLBI-sponsored clinical trial on triglycerides in coronary heart disease has completed. It re-evaluated whether triglyceride levels in…
-
FDA approval · 2016-02-19FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Gemfibrozil filed by Chartwell RX, LLC under an existing ANDA, indicating regulatory approval re…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Genetic Determinants:Low HDL, High Triglycerides, Obesity
NHLBI-sponsored clinical trial update examining genetic factors linked to low HDL, high triglycerides, and obesity and their relation to car…
-
CLINICAL_TRIALS research · 2016-02-10Clinical Trial Update: Genetic Epidemiology of Hypertriglyceridemia
A clinical trial update from the University of Washington describing a genetic epidemiology study of hypertriglyceridemia and related lipid …
-
CLINICAL_TRIALS withdrawal · 2016-02-08Clinical Trial Update: Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia [Phase 4]
A Phase 4 trial assessing Lovaza's impact on HDL composition and function in hypertriglyceridemia has been withdrawn.